The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mendelian Disorders Testing-Global Market Insights and Sales Trends 2024
Synopsis
The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the history of a family with the help of a family tree. This process of analysis is called the pedigree analysis.
The global Mendelian Disorders Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mendelian Disorders Testing in various end use industries. The expanding demands from the Hospitals, Specialty Clinc and Others,, are propelling Mendelian Disorders Testing market. Carrier Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Testing segment is estimated at % CAGR for the next seven-year period.
The different types of Mendelian disorders can be easily determined from the pedigree analysis. Few examples of the Mendelian disorder in humans are Sickle cell anemia, color blindness, muscular dystrophy, Thalassemia, cystic fibrosis, skeletal dysplasia, hemophilia, and phenylketonuria are the most common Mendelian disorders.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mendelian Disorders Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mendelian Disorders Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mendelian Disorders Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mendelian Disorders Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mendelian Disorders Testing covered in this report include Celera Group, Abbott Laboratories, ELITech Group, Quest Diagnostics, AutoGenomics, PerkinElmer, Roche Diagnostics, Bio-Rad Laboratories and Applied Biosystems, etc.
The global Mendelian Disorders Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
Transgenomic
Global Mendelian Disorders Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mendelian Disorders Testing market, Segment by Type:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Global Mendelian Disorders Testing market, by Application
Hospitals
Specialty Clinc
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mendelian Disorders Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the history of a family with the help of a family tree. This process of analysis is called the pedigree analysis.
The global Mendelian Disorders Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mendelian Disorders Testing in various end use industries. The expanding demands from the Hospitals, Specialty Clinc and Others,, are propelling Mendelian Disorders Testing market. Carrier Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Testing segment is estimated at % CAGR for the next seven-year period.
The different types of Mendelian disorders can be easily determined from the pedigree analysis. Few examples of the Mendelian disorder in humans are Sickle cell anemia, color blindness, muscular dystrophy, Thalassemia, cystic fibrosis, skeletal dysplasia, hemophilia, and phenylketonuria are the most common Mendelian disorders.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mendelian Disorders Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mendelian Disorders Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mendelian Disorders Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mendelian Disorders Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mendelian Disorders Testing covered in this report include Celera Group, Abbott Laboratories, ELITech Group, Quest Diagnostics, AutoGenomics, PerkinElmer, Roche Diagnostics, Bio-Rad Laboratories and Applied Biosystems, etc.
The global Mendelian Disorders Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
Transgenomic
Global Mendelian Disorders Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mendelian Disorders Testing market, Segment by Type:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Global Mendelian Disorders Testing market, by Application
Hospitals
Specialty Clinc
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mendelian Disorders Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Mendelian Disorders Testing
1.1 Mendelian Disorders Testing Market Overview
1.1.1 Mendelian Disorders Testing Product Scope
1.1.2 Mendelian Disorders Testing Market Status and Outlook
1.2 Global Mendelian Disorders Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mendelian Disorders Testing Market Size by Region (2018-2029)
1.4 Global Mendelian Disorders Testing Historic Market Size by Region (2018-2023)
1.5 Global Mendelian Disorders Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mendelian Disorders Testing Market Size (2018-2029)
1.6.1 North America Mendelian Disorders Testing Market Size (2018-2029)
1.6.2 Europe Mendelian Disorders Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Mendelian Disorders Testing Market Size (2018-2029)
1.6.4 Latin America Mendelian Disorders Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Mendelian Disorders Testing Market Size (2018-2029)
2 Mendelian Disorders Testing Market by Type
2.1 Introduction
2.1.1 Carrier Testing
2.1.2 Diagnostic Testing
2.1.3 New-Born Screening
2.1.4 Predictive & Pre-Symptomatic Testing
2.1.5 Prenatal Testing
2.2 Global Mendelian Disorders Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mendelian Disorders Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Mendelian Disorders Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mendelian Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mendelian Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mendelian Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mendelian Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mendelian Disorders Testing Revenue Breakdown by Type (2018-2029)
3 Mendelian Disorders Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinc
3.1.3 Others
3.2 Global Mendelian Disorders Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mendelian Disorders Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Mendelian Disorders Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mendelian Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mendelian Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mendelian Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mendelian Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mendelian Disorders Testing Revenue Breakdown by Application (2018-2029)
4 Mendelian Disorders Testing Competition Analysis by Players
4.1 Global Mendelian Disorders Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mendelian Disorders Testing as of 2022)
4.3 Date of Key Players Enter into Mendelian Disorders Testing Market
4.4 Global Top Players Mendelian Disorders Testing Headquarters and Area Served
4.5 Key Players Mendelian Disorders Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Mendelian Disorders Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Celera Group
5.1.1 Celera Group Profile
5.1.2 Celera Group Main Business
5.1.3 Celera Group Mendelian Disorders Testing Products, Services and Solutions
5.1.4 Celera Group Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Celera Group Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Mendelian Disorders Testing Products, Services and Solutions
5.2.4 Abbott Laboratories Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 ELITech Group
5.3.1 ELITech Group Profile
5.3.2 ELITech Group Main Business
5.3.3 ELITech Group Mendelian Disorders Testing Products, Services and Solutions
5.3.4 ELITech Group Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Mendelian Disorders Testing Products, Services and Solutions
5.4.4 Quest Diagnostics Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 AutoGenomics
5.5.1 AutoGenomics Profile
5.5.2 AutoGenomics Main Business
5.5.3 AutoGenomics Mendelian Disorders Testing Products, Services and Solutions
5.5.4 AutoGenomics Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.5.5 AutoGenomics Recent Developments
5.6 PerkinElmer
5.6.1 PerkinElmer Profile
5.6.2 PerkinElmer Main Business
5.6.3 PerkinElmer Mendelian Disorders Testing Products, Services and Solutions
5.6.4 PerkinElmer Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.6.5 PerkinElmer Recent Developments
5.7 Roche Diagnostics
5.7.1 Roche Diagnostics Profile
5.7.2 Roche Diagnostics Main Business
5.7.3 Roche Diagnostics Mendelian Disorders Testing Products, Services and Solutions
5.7.4 Roche Diagnostics Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Diagnostics Recent Developments
5.8 Bio-Rad Laboratories
5.8.1 Bio-Rad Laboratories Profile
5.8.2 Bio-Rad Laboratories Main Business
5.8.3 Bio-Rad Laboratories Mendelian Disorders Testing Products, Services and Solutions
5.8.4 Bio-Rad Laboratories Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Laboratories Recent Developments
5.9 Applied Biosystems
5.9.1 Applied Biosystems Profile
5.9.2 Applied Biosystems Main Business
5.9.3 Applied Biosystems Mendelian Disorders Testing Products, Services and Solutions
5.9.4 Applied Biosystems Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Applied Biosystems Recent Developments
5.10 Transgenomic
5.10.1 Transgenomic Profile
5.10.2 Transgenomic Main Business
5.10.3 Transgenomic Mendelian Disorders Testing Products, Services and Solutions
5.10.4 Transgenomic Mendelian Disorders Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Transgenomic Recent Developments
6 North America
6.1 North America Mendelian Disorders Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Mendelian Disorders Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mendelian Disorders Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mendelian Disorders Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mendelian Disorders Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mendelian Disorders Testing Market Dynamics
11.1 Mendelian Disorders Testing Industry Trends
11.2 Mendelian Disorders Testing Market Drivers
11.3 Mendelian Disorders Testing Market Challenges
11.4 Mendelian Disorders Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
